Cited by 334Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

FETSCH, T·2004·European Heart Journal

DOI 10.1016/j.ehj.2004.04.015

Open this paper in CoChat — free account

Abstract

AIMS: In patients with persistent atrial fibrillation (AF), the efficacy and safety of two anti-arrhythmic drugs in preventing the recurrence of AF after successful direct current (DC) cardioversion was prospectively assessed in a multi-centre double-blind, placebo-controlled, randomised trial using daily trans-telephonic monitoring. METHODS AND RESULTS: 1182 patients with persistent AF were prospectively enrolled, 848 patients were successfully cardioverted and then randomised to either sotalol (383 patients), quinidine plus verapamil (377 patients) or placebo (88 patients). The primary outcome parameter was AF recurrence or death. All patients received an event recorder (Tele-ECG) and had to record and transmit via telephone at least one ECG per day during follow-up. The mean follow-up period was 266 days. A total of 191,103 Tele-ECGs were recorded and transmitted. The primary outcome parameter (AF recurrence of any kind or death) was observed in 572 patients (67%) in whom at least one episode of AF recurrence was documented during follow-up, in 348 patients (41%) AF recurrence was persistent. The recurrence rates after one year for any AF were 83% for placebo, 67% for sotalol and 65% for quinidine plus verapamil, the latter being statistically superior to placebo but not different from sotalol. The recurrence rates for the secondary outcome parameter persistent AF were 77%, 49% and 38%, respectively. Quinidine plus verapamil was significantly superior to placebo and to sotalol. About 95% of all AF recurrences were initially detected in the daily Tele-ECG, about 70% of all AF recurrences occurred completely asymptomatic. Adverse events on sotalol and quinidine plus verapamil were comparable with the exception that all torsade de pointes tachycardias occurred on sotalol. CONCLUSION: Anti-arrhythmic treatment after DC cardioversion of persistent AF significantly decreases the recurrence rates of persistent AF compared to placebo with superiority of quinidine plus verapamil compared to sotalol. Symptoms were not reliable as clinical surrogates to detect episodes of AF.

Integrity signals

Registry

Crossref · 10.1016/j.ehj.2004.04.015

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M. R., Dorian, P., Connolly, S. J., Eisenberg, M. J., Green, M. S., Kuś, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,142
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C. (1990) · Circulation · doi:10.1161/01.cir.82.4.1106 · Cited by 946
Management of Patients With Atrial Fibrillation
Prystowsky, E. N., Benson, D. W., Fuster, V., Hart, R. G., Kay, G. N., Myerburg, R. J., Naccarelli, G. V., & Wyse, D. G. (1996) · Circulation · doi:10.1161/01.cir.93.6.1262 · Cited by 638
Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia
Page, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.1.224 · Cited by 627
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 491
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente‐Lafuente, C., Valembois, L., Bergmann, J., & Belmin, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub4 · Cited by 450
Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.
Juul‐Möller, S., Edvardsson, N. G., & Rehnqvist-Ahlberg, N. (1990) · Circulation · doi:10.1161/01.cir.82.6.1932 · Cited by 343
Verapamil Reduces Tachycardia-Induced Electrical Remodeling of the Atria
Tieleman, R. G., de Langen, C. D. J., Gelder, I. C. V., de Kam, P. J., Grandjean, J. G., Bel, K. J., WIJFFELS, M. C. E. F., Allessie, M. A., & Crijns, H. J. G. M. (1997) · Circulation · doi:10.1161/01.cir.95.7.1945 · Cited by 340
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
Anderson, J. L., Gilbert, E. M., Alpert, B. L., Henthorn, R. W., Waldo, A. L., Bhandari, A. K., Hawkinson, R. W., & Pritchett, E. L. C. (1989) · Circulation · doi:10.1161/01.cir.80.6.1557 · Cited by 287
Classification of atrial fibrillation
Gallagher, M. M., & Camm, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00736-x · Cited by 167

Show all 27 references

Sorted by citations

Items 201–300 of 334

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation
Lenhoff, H., Darpö, B., Page, A., Couderc, J. P., Tornvall, P., & Frick, M. (2021) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12834 · Cited by 2
EKG-Diagnostik von Vorhofflimmern
Eitel, C., Hindricks, G., Sommer, P., & Müssigbrodt, A. (2012) · Nervenheilkunde · doi:10.1055/s-0038-1628224 · Cited by 2
Vorhofflimmern und körperliche Aktivität
Laszlo, R., & Steinacker, J. M. (2015) · Herz · doi:10.1007/s00059-015-4352-x · Cited by 2
Prise en charge de la fibrillation atriale chez les patients implantés d’un stimulateur ou défibrillateur cardiaque : les possibilités offertes par la télécardiologie
Amara, W. (2008) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2008.07.003 · Cited by 2
Cytochrome P450-2D6 Genotype Definition May Improve Therapy for Paroxysmal Atrial Fibrillation A Case of Syncope Following "Pill-in-the-Pocket" Quinidine plus Propafenone.
D, H. W. D. M. (2014) · Europe PMC (PubMed Central) · doi:10.4022/jafib.978 · Cited by 2
Therapie von Vorhofflimmern
Kirchhof, P. F., & BREITHARDT, G. E. (2007) · Der Internist · doi:10.1007/s00108-007-1899-5 · Cited by 2
Assessment of Potential Primary and Recurrent Ischemic Stroke by Detecting Atrial Fibrillation using 1D-CNN and CHA2DS2-VA Score
Mamun, M. M. R. K. (2021) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm52615.2021.9669885 · Cited by 2
Review of Recent Trials of Medical Therapy for Atrial Fibrillation
Stuglin, C., & Wyse, D. G. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-163-5_11 · Cited by 2
Postoperatives Vorhofflimmern
Knaut, M., Sindt, M., & Madej, T. (2017) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-017-0140-7 · Cited by 4
Bedeutung der Anamnese und der Umsetzung von Therapieleitlinien bei Rhythmuspatienten
Meesmann, M. (2007) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-007-0556-y · Cited by 2
Vorhofflimmern: Frequenz- oder Rhythmuskontrolle—
Schwab, J. O., & Lüderitz, B. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-1412-x · Cited by 2
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
SHELTON, R. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.08.022 · Cited by 2
Antiarrhythmic drug treatment after cardioversion of atrial fibrillation – Authors' reply
Kirchhof, P. F., BREITHARDT, G. E., Treszl, A., & Wegscheider, K. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61834-0 · Cited by 2
Cardiología (ESC) Desarrolladas con la contribución especial de European Heart Rhythm Association (EHRA) Aprobado por European Association for Cardio-Thoracic Surgery (EACTS)
Camm, A. J., Kirchhof, P. F., Ernst, S., Gelder, I. C. V., Hindricks, G., Heidbüchel, H., Colonna, P., Goette, A., Hohloser, S. H., Kolh, P. H., et al. (2010) · Cited by 2
Vorhofflimmern
Hennersdorf, M., & Strauer, B. E. (2006) · Der Internist · doi:10.1007/s00108-006-1693-9 · Cited by 2
Kardioversion von Vorhofflimmern und –flattern
Reisinger, J., & Siostrzonek, P. (2005) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Effect of amiodarone treatment on outcome after direct current cardioversion in atrial fibrillation: Should we cardiovert atrial fibrillation of longer duration
Agarwal, S. C., & Pepper, C. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.05.060 · Cited by 1
The burden of atrial fibrillation
Weidtmann, B., Demming, T., & Bonnemeier, H. (2010) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-010-0002-2 · Cited by 1
Is There a Role for Bi-Atrial Pacing Resynchronisation Therapy in the Management of Drug-Refractory Atrial Fibrillation in Patients Unsuitable for Left Atrial Ablation?
Sankaranarayanan, R., James, M. A., Gonna, H., Burtchaell, S., Holloway, R., & Ewings, P. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0571 · Cited by 1
The Effects of a Bidirectional Cavo-Tricuspid Isthmus Block in Persistent Atrial Fibrillation
Kim, J., Choi, S., Joung, B., Lee, M., & Kim, S. S. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.1.76 · Cited by 1
Comparison between Carotid Artery Doppler Ultrasound and Coronary Calcium Score as Predictors of Significant Coronary Artery Disease in Patients Undergoing Computed Tomography Coronary Angiography
Tresoldi, S. (2014) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000116 · Cited by 1
Pharmacologic targets for atrial fibrillation
Bhakta, D., & Miller, J. M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1161 · Cited by 1
Anti-arrhythmic Drugs
Glover, B. M., & Dorian, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-40818-7_10 · Cited by 1
Atrial Fibrillation
ZIMETBAUM, P. J., & Falk, R. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00020-5 · Cited by 1
Event-Rekorder
Schuchert, A. (2008) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-008-0011-8 · Cited by 1
Herztherapeutika
Thomas Eschenhagen, A. (2013) · Springer eBooks · doi:10.1007/978-3-642-37124-0_27 · Cited by 1
Herztherapeutika
Thomas Eschenhagen, A. (2014) · Springer eBooks · doi:10.1007/978-3-662-43487-1_26 · Cited by 1
Herztherapeutika
Eschenhagen, T. (2016) · Springer eBooks · doi:10.1007/978-3-662-50351-5_28 · Cited by 1
Incidence of atrial fibrillation paroxysms in chronic heart failure patients with preserved and reduced ejection fraction
Zakharov, I. P., Borenstein, A. I., Kuznetsova, N., Парисович, С. В., Kopylov, P., Andreev, D. A., & Chomakhidze, P. S. (2023) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio20231601156 · Cited by 1
Determining The Risk of Atrial Fibrillation Paroxysm in Patients With Chronic Heart Failure With Intact and Reduced Ejection Fraction
Zakharov, I. P., Chomakhidze, P. S., Kopylov, F. Y., Sultygova, E. A., Фератовна, М. Д., Lyubimova, E. A., & Andreev, D. A. (2024) · Kardiologiia · doi:10.18087/cardio.2024.3.n2466 · Cited by 1
Herzerkrankungen
Eschenhagen, T., & Weil, J. (2025) · Springer eBooks · doi:10.1007/978-3-662-70594-0_7 · Cited by 1
Evaluation of Early and Intermediate Outcomes of Cryo-MazeProcedure for Atrial Fibrillation
Yaghoubi, A., Rostamzadeh, M., Pezeshkian, M., Parvizi, R., & Imani, S. (2013) · Europe PMC (PubMed Central) · doi:10.5681/jcvtr.2013.012 · Cited by 1
Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial
Cappato, R., Ezekowitz, M. D., Hohnloser, S. H., Meng, I. L., Wosnitza, M., & Camm, A. A. J. (2021) · EP Europace · doi:10.1093/europace/euab084 · Cited by 1
Quinidine☆
Cataldi, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99384-x · Cited by 1
Pharmakologische Therapie bei Vorhofflimmern – Was leisten moderne Antiarrhythmika wirklich?
Volkmann, H., Richter, L., & Bergmann, C. (2008) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-008-0034-z · Cited by 1
Atrial Fibrillation: Rhythm and Rate Control Therapies
Savelieva, I., Waldo, A. L., & Camm, A. J. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch35 · Cited by 1
Epidemiologie von Vorhofflimmern
Gerth, A., Höss, J., Näbauer, M., & Steinbeck, G. (2006) · Steinkopff eBooks · doi:10.1007/3-7985-1632-4_2 · Cited by 1
Atrial fibrillation—rate or rhythm control?
Gonska, B. (2010) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-010-0006-y · Cited by 1
Quinidine plus verapamil vs. quinidine alone to prevent recurrences of atrial fibrillation
Veloso, H. H. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi324 · Cited by 1
Catheter ablation for atrial fibrillation: pathophysiology, techniques, results and current indications
Scharf, C., Schläpfer, J., Sticherling, C., Osswald, S., Fuhrer, J., & Shah, D. C. (2005) · Kardiovask Med · doi:10.4414/cvm.2005.01074 · Cited by 1
Asymptomatisches Vorhofflimmern bei systematischem Screening mittels Tele-EKG: —Bedeutung für die Antikoagulation bei paroxysmalem Vorhofflimmern
Patten, M. (2005) · Herzschrittmachertherapie + Elektrophysiologie · Cited by 1
Tachykarde Rhythmusstörungen
SCHRICKEL, J. W., Beiert, T., & Andrié, R. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23834-5.00013-x · Cited by 1
Atrial Fibrillation and Heart Failure in the Aging Population
Kazemian, P., & Jugdutt, B. I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0268-2_5
Peri-operative atrial fibrillation in cardiac surgery : impact on outcome
Bramer, S. (2013) · doi:10.26481/dis.20131018sb
Drug Therapy for Rhythm and Rate Control in Atrial Fibrillation
Soldevila, J. G., & Martínez‐Rubio, A. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5475-4_5
Rationelle Therapie von Vorhofflimmern in der Intensivmedizin
Hoffmann, B. A., Wilke, I., Drewitz, I., Steven, D., Rostock, T., & Willems, S. (2009) · Intensivmedizin und Notfallmedizin · doi:10.1007/s00390-009-0056-x
Nichtinvasive Untersuchungsmethoden bei Vorhofflimmern/Vorhofflattern
Andresen, D., Brüggemann, T., Ehlers, C., & Wiedemann, M. (2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1748-6_6
Aspectos epidemiológicos, clínicos y terapéuticos de la fibrilación auricular aguda
García, D. V., González, L. M. L., Machado, L. J., & Sánchez, K. G. (2010) · DOAJ (DOAJ: Directory of Open Access Journals)
17 Positive inotropic drugs and drugs used in dysrhythmias
Aronson, J. K. (2007) · Side effects of drugs annual · doi:10.1016/s0378-6080(06)29017-2
Combination Antiarrhythmic Therapy: 1 + 1>2?
TANG, L. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01222.x
Medikamentöse Therapie von Vorhofflimmern
Sinha, A. M., Brachmann, J., & Schmidt, M. U. (2008) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-008-0005-6
Beta-Blocker Therapy for Septic Cardiac Shock: Fiction Or Realism?
Bendjelid, K. (2006) · Current Drug Therapy · doi:10.2174/157488506776930941
Aktuelle Therapiestrategien bei Vorhofflimmern
Drewitz, I., Rostock, T., Hoffmann, B. A., Steven, D., Servatius, H., Meinertz, T., Willems, S., & (AFNET)*, U. M. D. K. V. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1123-y
Epidemiologie und Prognose
Schuchert, A., & Meinertz, T. (2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1748-6_2
Role of sotalol in rhythm control of atrial fibrillation
Marinelli, A., Rosi, A., & Capucci, A. (2010) · Therapy · doi:10.2217/thy.10.37
Cardiovert!—or better wait a little? Systematic evidence that the initial hours of atrial fibrillation are a “special time”
Kirchhof, P. F. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.10.004
Vorhofflimmern und Blutungskomplikationen
Ravens, U., Kirchhof, P. F., Gelder, I. C. V., & Breithardt, G. (2012) · Nervenheilkunde · doi:10.1055/s-0038-1628223
Pharmacologic Management of Atrial Fibrillation and Flutter
Saluja, D. S., Hickey, K. T., & Reiffel, J. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-161-5_8
The Application of Spectral Analysis of the Surface Electrocardiography Prior to Direct Current Cardioversion in Patients with Persistent Atrial Fibrillation
Jia, R. (2012) · Otago University Research Archive (University of Otago)
Verlaufskontrolle nach Katheterablation von Vorhof- flimmern: Bedeutung asymptomatischer Arrhythmierezidive *
Sommer, P., Piorkowski, C., Kottkamp, H., Arya, A., Gerds‐Li, J., Esato, M., Riahi, S., & Hindricks, G. (2007) · Journal für Kardiologie
Asymptomatic Atrial Fibrillation After Cryptogenetic Stroke
Raviele, A. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.002835
Bewertung des Langzeitverlaufs nach Katheterablation von intermittierendem und persistierendem Vorhofflimmern mittels Tele-EKG: Prognostische und therapeutische Implikationen.
Brandstrup, B. (2008)
Preventing Recurrences: Classic and Modern Antiarrhythmic Drugs in Atrial
Víctor, F., Jorge, T. R., & Lozano, I. F. (2015)
How Can We Avoid a Stroke Crisis in Europe
Andreotti, F., Camm, A. J., & Lobban, T. (2012)
FIBRILACE SÍNÍ - FIBRILACE SÍNÍ - TERAPEUTICKÉ POSTUPY A CÍLE TERAPEUTICKÉ POSTUPY A CÍLE
LUKL, J. (2005)
German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association
Kirchhof, P. F., Auricchio, A., Bax, J. J., Crijns, H. J. G. M., Camm, A. J., Diener, H., Goette, A., Hindricks, G., Hohnloser, S. H., Kück, K., et al. (2007)
Telemedizin in der Rhythmologie
Volkmann, H., Bergmann, C., & Walter, M. (2007) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-007-0014-8
We declare that we have no confl icts of interest.
Schwab, M. G., Moerike, K., Kirchhof, P. F., Smit, M. D., Moes, M. L., & Gelder, I. C. V. (2012)
Fibrillazione analisi epidemiologica
Ovsyshcher, I. E. (2005)
Torsade de pointes bei Medikamenten-induzierter abnormer QT-Verlängerung: Einfluß von Alter und Geschlecht
Breithardt, G. (2006)
Electrocardiographic Markers of Cardioversion Success in Patients with Atrial Fibrillation or Flutter
Heston, T. F., & Cheng, A. (2009) · Southern Medical Journal · doi:10.1097/smj.0b013e3181b08a4d
Diagnose Vorhofflimmern
Meesmann, M. (2013) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-013-0269-3
New Antiarrhythmic Drugs and New Concepts for Old Drugs
Kirchhof, P. F. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00112-6
Management of atrial fibrillation: when are invasive approaches useful?
Honarbakhsh, S., Finlay, M., Earley, M., Lambiase, P. D., Schilling, R., & Hunter, R. (2016) · British Journal of Hospital Medicine · doi:10.12968/hmed.2016.77.8.460
Telecardiology Tools and Devices
Müller, A., SCHWAB, J. O., Zugck, C., Schweizer, J., & Helms, T. M. (2018) · CRC Press eBooks · doi:10.1201/9781351229067-21
Prozess- und Diagnosequalität in Präklinik und Notaufnahme des Universitätsklinikums Göttingen
Muller, G. A., & Medizin, I. (2010)
Quinidine Plus Verapamil Beats Sotalol for AF Suppression
Christenson, J. M., & Frcpc (2004) · Journal watch · doi:10.1056/em200411100000001
Atrial fibrillation monitoring to reduce thromboembolic risk: Selecting the patient and the monitoring device
Barra, S., & Providencia, R. A. (2017) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2016.12.011
Innovations in Antiarrhythmic Drug Therapy
Kirchhof, P. F., & Fabritz, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00113-9
ALTERNATIVAS TERAPÉUTICAS EN FIBRILACIÓN AURICULAR
Altamirano, R. (2018) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2018.02.008
Therapie von tachykarden Herzrhythmusstörungen
SCHRICKEL, J. W., & Andrié, R. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-24950-1.00012-3
Therapie von Herzrhythmusstörungen
Steven, D., Willems, S., & Meinertz, T. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22107-1.50086-8
18 Beta-adrenoceptor antagonists and antianginal drugs
Maggioni, A. P., Franzosi, M. G., & Latini, R. (2007) · Side effects of drugs annual · doi:10.1016/s0378-6080(06)29018-4
Atrial Fibrillation
Kumar, S., & Michaud, G. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00076-6
Atrial Fibrillation Episodes of Illness in a Primary Care Setting
Tarasevich, A. (2019) · Scholarship@Western (Western University)
Endpunkte für Studien bei Patienten mit Vorhofflimmern: Bericht über ein Konsensus-Papier von AFNET und EHRA
Kirchhof, P. F., Goette, A., Hindricks, G., Hohnloser, S. H., Kück, K., Meinertz, T., Ravens, U., Steinbeck, G., & Breithardt, G. (2007) · Herzschrittmachertherapie + Elektrophysiologie
Control Of Hypertension Improves The Outcome Of Therapies For Paroxysmal And Persistent Atrial Fibrillation.
Hayes, C. (2014) · PubMed Central · doi:10.4022/jafib.1092
Atrial Fibrillation
ZIMETBAUM, P. J., & Falk, R. H. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50030-9
Kardiovaskuläre Erkrankungen
(2011) · Elsevier eBooks · doi:10.1016/b978-3-437-22702-8.50006-6
Antithrombotic therapy in multimorbid patients with atrial fibrillation from standpoint of clinical recommendations of Ministry of Health of Russian Federation (2020). Effectiveness and safety of apixaban in patients with atrial fibrillation and concomitant diseases
Ostroumova, O. D., Butorov, V. N., Arablinsky, N. A., Romanovsky, R. R., & Владимировна, Б. С. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-11-12-19
Thromboembolieprophylaxe bei Vorhofflimmern
Volkmann, H., Walter, M., Bergmann, C., Rose, E., Krpčiar, V., & Vetter, S. (2009) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-009-0046-5
Thromboembolieprophylaxe bei Vorhofflimmern : Wann orale Antikoagulanzien? Wann Aspirin? Wann Heparine? Wann Kombinationen? (Schwerpunkt)
Volkmann, H., Walter, M., Bergmann, C., Rose, E., Krpčiar, V., & Vetter, S. Y. (2009) · Herzschrittmachertherapie + Elektrophysiologie
Vorhofflimmern: Frequenz- oder Rhythmuskontrolle—: Welche Strategie für welchen Patienten?
Schwab, J. O., & Lüderitz, B. (2005) · Zeitschrift für Kardiologie
Therapie des Vorhofflimmerns
Pfeiffer, D., Salameh, A., & Hagendorff, A. (2006) · Steinkopff eBooks · doi:10.1007/3-7985-1632-4_11
Vorhofflimmern: Medikamente oder Ablation
Metzner, A., Rillig, A., & Kirchhof, P. F. (2020) · Deutsches Ärzteblatt · doi:10.3238/perskardio.2020.04.10.03
Herztherapeutika
Eschenhagen, T. (2021) · Springer eBooks · doi:10.1007/978-3-662-63825-5_27
Biosignalverarbeitung
Schnupp, T., Heinze, C., Groß, H.-M., & Golz, M. (2010) · Biomedizinische Technik/Biomedical Engineering · doi:10.1515/bmt.2010.705
Common Atrial and Ventricular Arrhythmias
Foreman, B. W. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_23
Antiarrhythmika
Thomas Eschenhagen, A., & Scholz, H. (2004) · Springer eBooks · doi:10.1007/978-3-642-18513-7_9
Antiarrhythmic agents and torsades de pointes
Wass, S. Y., & Chung, M. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821446-6.00005-5

Authors: FETSCH, T.
Affiliations: University Hospital Münster (DE)
Corresponding author: FETSCH, T
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2004-08
Volume: 25
Issue: 16
Pages: 1385-1394
ISSN: 0195-668X (ISSN-L)
DOI: 10.1016/j.ehj.2004.04.015
OpenAlex: W2126416532
Cited by: 334
References: 27
Citations by year: 2026: 2 · 2025: 8 · 2024: 9 · 2023: 8 · 2022: 2 · 2021: 11 · 2020: 7 · 2019: 7 · 2018: 13 · 2017: 13 · 2016: 15 · 2015: 11 · 2014: 10 · 2013: 14 · 2012: 20
FWCI: 17.62
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: persistent atrial fibrillation, atrial fibrillation recurrence, electrical cardioversion, sotalol, quinidine, verapamil, antiarrhythmic drugs, remote patient monitoring, event data recorders, torsades de pointes
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Anti-Arrhythmia Agents, Atrial Fibrillation, Double-Blind Method, Drug Therapy, Combination, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Quinidine, Sotalol, Verapamil, Survival Analysis, Treatment Outcome, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks